🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Vigtig viden deles👏🏼👏🏼- tak Anne Tjønneland & Kræftens Bekæmpelse DCCC

Super proud of #ESMOYOC team and grateful to Jon Lim, MRCP PhD for leading on such an important position paper on role and future of the clinician-scientist in #oncology, a key topic for many YOs ESMO Open ESMO - Eur. Oncology OncoAlert AIOM Teresa Amaral, MD, PhD Università di Genova sciencedirect.com/science/articl…

🤖Artificial intelligence as an adjunct tool for breast oncologists – are we there yet? Read this new editorial just published by Ilana Schlam Saad Menezes, Adrian Y Tan, Chiara Corti Inas Abuali, MD Sara Tolaney to find out! sciencedirect.com/science/articl…

See our clinically important paper on obesity & inferior breast cancer prognosis - NEXT STEP: how do we circumvent this?? Sixten Dee Cronin Fenton ObeCaRe Department of Oncology, Aarhus University Hospital Department of Clinical Epidemiology, Aarhus Aarhus Uni.hospital @HealthAarhusUni Nationalt Center for Overvægt Kræftens Bekæmpelse

Always a great privilege and joy to collaborate with such talented colleagues🙏🏻🙏🏻🙏🏻 - thank you all for all efforts to get this important publication out paving way for improving health in cancer patients ❤️

Powerful words in horrible times😢let”s hope the world is listening instagram.com/reel/CygWv0mI4…

Obesity Linked to Increased Recurrence Rates in Breast Cancer curetoday.com/view/obesity-l… Thanks Cure for the chat and for featuring our latest paper 📄

Magnificent contributions from Sixten Jonas Busk Holm Pernille Skovlund in the field of obesity & cancer ObeCaRe Department of Oncology, Aarhus University Hospital

Attending #SABCS2023 remotely from lovely Skagen with this superb team of colleagues Birgitte Offersen Trine Tramm Sixten Jonas Busk Holm Jeppe Skovbjerg Kristine Høgsbjerg Pernille Skovlund Martin & Lærke Department of Oncology, Aarhus University Hospital Aarhus Universitet

Sikke en fantastisk dag! Samarbejde er ordet!

Enjoying ESMO Breast 2024 with these amazing talents🇩🇪☀️💖 Jonas Busk Holm Sixten Kasper Kjærgaard Jeppe Skovbjerg @KirstenWoolpert #ESMOBreast24

Great morning at #ESMOBreast24 - awaiting our talented PhD-student Sixten at Department of Oncology, Aarhus University Hospital to talk - emulated target trial with statins in #breastcancer

Emulated target trial looking at #statins in early #bcsm Those that received statins had ⬆️ survival. 🎯 Question is what other healthy behaviors are associated with statin use? Hard to conclude much with study design, MASTER randomized will help. #ESMOBreast24 ESMO - Eur. Oncology

At #ESMOBreast24: In a Danish population-based cohort 🇩🇰 study statin use ⬇️ breast cancer mortality 💊 Validation in prospective randomized trials is needed‼️ A phase 3 trial is ongoing classic.clinicaltrials.gov/ct2/show/NCT04… OncoAlert

📄 #Breastcancer survivors with #metabolicsyndrome have shorter disease-free survival than those without metabolic syndrome. #ESMOBreast24 #oncologynews ESMO - Eur. Oncology 🗞️ Read More: buff.ly/4dH8czf

Important point by Erika Hamilton, MD. A common questions from pts is: what should I take (or eat) to reduce my risk of recurrence? The answer to this question should not come from retrospective studies, often burdened by confounding bias, but should derive from RCTs. #ESMOBreast24

So happy to be at the #ESMOBreast24 and share our results on the impact of metabolic syndrome on breast cancer outcomes🔬 BC patients with metabolic syndrome have poorer outcomes compared to their peers without metabolic syndrome ‼️ Read DocWire News coverage of our study📰

Thank you for highlighting our research results - timely to consider metabolic screening among cancer patients! Jonas Busk Holm Jens Meldgaard Bruun Nationalt Center for Overvægt Research @ Steno Diabetes Center Aarhus Steno Diabetes Center Odense

Obesity➡️ worse prognosis & different biology #breastcancer. Still, BMI is only reported in 8% of 495 trials we reviewed. More research needed to study impact of BMI on treatment efficacy and toxicity🙏 ! Josephine Van Cauwenberge KarenVanBaelen OncoAlert doi.org/10.1186/s13058…

At #ESMOBreast2025, Dr. Sixten shared an analysis from the Nurses’ Health Study showing that weight gain after diagnosis may raise #breastcancer death risk. Study followed 6,800+ women between 1978 - 2018, with follow-up ranging from 4–15 years. 🔗bit.ly/ESMO2025